Join Free For Buyer|Sign In

Professional Online Trade Platform for API, Preparation and Pharmaceutical Machinery and Equipment_EN-CPhI.cn

You are here:  Home >>  News >>  Conference & Exhibition >>  bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia

bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia

December 17, 2018 By en-cphi.cn

bioLIVE China 2019

June 18-20, 2019, SNIEC, Shanghai, China

Organizer: UBM EMEA, CCCMHPIE

Co-organizer: UBM Sinoexpo

bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia

The bio-pharma industry has entered the new stage of rapid development in recent years with the continuous development of the cutting-edge biological technology and the emerging and marketing of new targeted drugs and cell therapies, etc. From the perspective of global market size, sales of the global biotech drugs are expected to account for more than one third of all the sales revenue of pharmaceutical products by 2020. According to the statistics of InSight, in 2017, the biological drug applications reached the highest level in China in recent 5 years, with a total of 616. And Frost & Sullivan forecasts that the biological drug market size will reach RMB 326.9 billion in China in 2021, with the growth rate ranking high in the world.

The bio-pharma display platform with 7 years of historical accumulation in China—BioPh China will be newly upgraded into bioLIVE China on June 18-20, 2019. bioLIVE China 2019 will focus on life science, biotechnology, and innovative drugs, lead the bio-medicine technology innovation and industry development, and interact with industry high-end conferences. Together with CPhI China 2019 in SNIEC, bioLIVE China will jointly create a leading whole-industry-chain annual gala of the pharmaceutical industry in Asia.

bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia

To comprehensively showcase the industry’s leading technologies, with the participation of 150+ bio-pharma exhibitors

bioLIVE China 2019 will gather top biopharmaceutical products and R&D information inside and outside China, and is expected to attract 150+ well-known enterprises including 3SBio, Sinobioway, Dongbao Pharmaceutical, Gan & Lee Pharmaceuticals, GenScript Biotech, Hualan Bio, Hybio Pharmaceutical, and Frontier Biotechnologies to join. It is becoming a first choice for bio-pharma enterprises to publicize brands and expand markets, by virtue of the exhibition platform advantages of high internationalization degree and full coverage of the pharmaceutical industry!

bioLIVE China 2019, a leader in Asian biopharmaceutical exhibitions, will centrally showcase advanced technologies in the three areas: biological products and emerging therapies; bioprocessing, manufacturing and solutions; and biotechnology and R&D services. It is expected to gather more than 20,000 Chinese and overseas professional buyers and researchers in Shanghai, to provide professionals in biotechnology, new drug R&D, and pharmaceutical investment areas, etc. with an industry-leading platform for information exchange and international trade expansion.

bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia

To gather Chinese and overseas experts, and initiate a top summit forum of the bio-pharma industry

bioLIVE China will enter into deep cooperation with international professional biotechnology organizations, bio-pharma enterprises, and high-end bio-pharma technological and financial talents in 2019, to roll out the industry top summit forum—Bio S&T which will focus on the new scientific thoughts (Science) and new technological developments (Technology) of bio-pharmaceuticals, to provide the rapidly developing bio-pharma industry a platform to regularly showcase itself and get the latest information of the industry.

Concurrently with the exhibition, Bio S&T will hold three-day high-end biotechnology meetings, to keep track of the development trends of the bio-medicine industry in recent years; it will invite over 30 senior pharmaceutical experts inside and outside China to form a luxury speaker lineup to combine meeting and exhibition through the three topics of therapeutic monoclonal antibodies, GMP production of macromolecular biopharmaceutical products, and biotechnology investment, and will gather individuals and enterprises, and upstream and downstream experts and users to conduct multidimensional exchanges and interactions; it will drive development through technological innovation, and achieve win-win through mutually beneficial cooperation, to boost the bio-pharma industry to flourish.

Visit the exhibition website http://www.cphi-china.cn/biolive/en now to register online and join the annual event of the biopharmaceutical industry, and have face-to-face exchanges with the industry giants!

 

Contact us:

Ms. Yingqi Shi

E: yingqi.shi@ubmsinoexpo.com

T: +86 21-33392421

 

Readers'Comments
Add a comment
Click here to Login or to Register for free. You will be taken back to your selected item after Login/Registration.
More>> MarketNews
More>> Editors’Picks
More>> TopStories
More>> HotTags
Follow Us
CPhI Online Trade Platform: Worldwide|English|中国站
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)
About Us| Contact Us| Terms of Services| Privacy Policy| Intellectual Property Statement| Links | Site Map
Copyright 2006-20 Shanghai UBM Sinoexpo International Exhibition Co Ltd (All Rights Reserved). ICP 05034851-53
网页对话
live chat